Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85.9M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
40.4M
-
Shares change
-
+8.23M
-
Total reported value, excl. options
-
$180M
-
Value change
-
+$37.7M
-
Number of buys
-
51
-
Number of sells
-
-21
-
Price
-
$4.46
Significant Holders of Stereotaxis, Inc. - Common Stock, par value $0.001 per share (STXS) as of Q2 2020
82 filings reported holding STXS - Stereotaxis, Inc. - Common Stock, par value $0.001 per share as of Q2 2020.
Stereotaxis, Inc. - Common Stock, par value $0.001 per share (STXS) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.4M shares
of 85.9M outstanding shares and own 46.99% of the company stock.
Largest 10 shareholders include DAFNA Capital Management LLC (13.7M shares), Arbiter Partners Capital Management LLC (4.45M shares), Consonance Capital Management LP (3.66M shares), Opaleye Management Inc. (3.51M shares), Redmile Group, LLC (3.1M shares), BlackRock Inc. (2.67M shares), VANGUARD GROUP INC (1.81M shares), PURA VIDA INVESTMENTS, LLC (902K shares), MILLENNIUM MANAGEMENT LLC (692K shares), and Parkman Healthcare Partners LLC (669K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.